Sharma P, Abramson VG, O'Dea AP, Nye L, et al. Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer. Clin Cancer Res 2021 Feb 18. pii: 1078-0432.CCR-20-4879.
PMID: 33602685